How does comorbidity affect cost of health care in patients with irritable bowel syndrome? A cohort study in general practice

BMC Gastroenterology

Volumn 10, Issue , 2010, Pages

  Johansson, Per A ^a   Farup, Per G ^a,b   Bracco, Andrea ^c   Vandvik, Per O ^a  

^a INNLANDET HOSPITAL TRUST   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ALCOHOL CONSUMPTION; ALTERNATIVE MEDICINE; ANXIETY; ARTICLE; BARIUM ENEMA; BLOOD EXAMINATION; COHORT ANALYSIS; COMORBIDITY; CONSULTATION; DISEASE SEVERITY; DRUG USE; DYSPEPSIA; EDUCATIONAL STATUS; ENDOSCOPY; FEMALE; GENDER; GENERAL PRACTICE; HEALTH CARE COST; HOSPITAL COST; HOSPITALIZATION; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MEDICAL LEAVE; MOOD DISORDER; NEUROSIS; SCORING SYSTEM; SMOKING; SOMATIC SYMPTOM; SYMPTOM; DRINKING BEHAVIOR; ECONOMICS; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HEALTH CARE PLANNING; MENTAL DISEASE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NORWAY; STATISTICS; UTILIZATION REVIEW;

ALCOHOL DRINKING; COHORT STUDIES; COMORBIDITY; DYSPEPSIA; FAMILY PRACTICE; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; HEALTH CARE COSTS; HEALTH RESOURCES; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MENTAL DISORDERS; MIDDLE AGED; MOOD DISORDERS; MULTIVARIATE ANALYSIS; NORWAY; SMOKING;

EID: 77953936579     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-10-31     Document Type: Article

References (25)

1. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993, 38:1569-1580. 10.1007/BF01303162, 8359066.
2. Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 2003, 17:643-650. 10.1046/j.1365-2036.2003.01456.x, 12641512.
3. Vandvik PO, Lydersen S, Farup PG. Prevalence, comorbidity and impact of irritable bowel syndrome in Norway. Scand J Gastroenterol 2006, 41:650-656. 10.1080/00365520500442542, 16716962.
4. Badia X, Mearin F, Balboa A, Baro E, Caldwell E, Cucala M, et al. Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria. Pharmacoeconomics 2002, 20:749-758. 10.2165/00019053-200220110-00004, 12201794.
5. El-Serag HB, Olden K, Bjorkman D. Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 2002, 16:1171-1185. 10.1046/j.1365-2036.2002.01290.x, 12030961.
6. Spiegel BM, Kanwal F, Naliboff B, Mayer E. The impact of somatization on the use of gastrointestinal health-care resources in patients with irritable bowel syndrome. Am J Gastroenterol 2005, 100:2262-2273. 10.1111/j.1572-0241.2005.00269.x, 16181379.
7. Maxion-Bergemann S, Thielecke F, Abel F, Bergemann R. Costs of irritable bowel syndrome in the UK and US. Pharmacoeconomics 2006, 24:21-37. 10.2165/00019053-200624010-00002, 16445300.
8. Akehurst RL, Brazier JE, Mathers N, O'Keefe C, Kaltenthaler E, Morgan A, et al. Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting. Pharmacoeconomics 2002, 20:455-462. 10.2165/00019053-200220070-00003, 12093301.
9. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?. Gastroenterology 2002, 122:1140-1156. 10.1053/gast.2002.32392, 11910364.
10. Vandvik PO, Wilhelmsen I, Ihlebaek C, Farup PG. Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications. Aliment Pharmacol Ther 2004, 20:1195-1203. 10.1111/j.1365-2036.2004.02250.x, 15569123.
11. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999, 45(Suppl 2):II43-II47. 1766683, 10457044.
12. Eriksen HR, Ihlebaek C, Ursin H. A scoring system for subjective health complaints (SHC). Scand J Public Health 1999, 27:63-72. 10.1177/14034948990270010401, 10847674.
13. Grayson DA. Latent trait analysis of the Eysenck Personality Questionnaire. J Psychiatr Res 1986, 20:217-235. 10.1016/0022-3956(86)90005-1, 3772823.
14. Speckens AE, Spinhoven P, Sloekers PP, Bolk JH, van Hemert AM. A validation study of the Whitely Index, the Illness Attitude Scales, and the Somatosensory Amplification Scale in general medical and general practice patients. J Psychosom Res 1996, 40:95-104. 10.1016/0022-3999(95)00561-7, 8730649.
15. Strand BH, Dalgard OS, Tambs K, Rognerud M. Measuring the mental health status of the Norwegian population: a comparison of the instruments SCL-25, SCL-10, SCL-5 and MHI-5 (SF-36). Nord J Psychiatry 2003, 57:113-118. 10.1080/08039480310000932, 12745773.
16. Koloski NA, Talley NJ, Boyce PM. Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychosocial factors. Am J Gastroenterol 2001, 96:1340-1349. 10.1111/j.1572-0241.2001.03789.x, 11374666.
17. Creed F, Ratcliffe J, Fernandez L, Tomenson B, Palmer S, Rigby C, et al. Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome. Ann Intern Med 2001, 134:860-868.
18. Longstreth GF, Wilson A, Knight K, Wong J, Chiou CF, Barghout V, et al. Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective. Am J Gastroenterol 2003, 98:600-607. 10.1111/j.1572-0241.2003.07296.x, 12650794.
19. Pincus T, Burton AK, Vogel S, Field AP. A systematic review of psychological factors as predictors of chronicity/disability in prospective cohorts of low back pain. Spine (Phila Pa 1976) 2002, 27:E109-E120.
20. Ritzwoller DP, Crounse L, Shetterly S, Rublee D. The association of comorbidities, utilization and costs for patients identified with low back pain. BMC Musculoskelet Disord 2006, 7:72. 10.1186/1471-2474-7-72, 1584237, 16982001.
21. Spiegel BM, Gralnek IM, Bolus R, Chang L, Dulai GS, Mayer EA, et al. Clinical determinants of health-related quality of life in patients with irritable bowel syndrome. Arch Intern Med 2004, 164:1773-1780. 10.1001/archinte.164.16.1773, 15364671.
22. Ford AC, Talley NJ, Schoenfeld PS, Quigley EM, Moayyedi P. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut 2009, 58:367-378. 10.1136/gut.2008.163162, 19001059.
23. Creed F, Tomenson B, Guthrie E, Ratcliffe J, Fernandes L, Read N, et al. The relationship between somatisation and outcome in patients with severe irritable bowel syndrome. J Psychosom Res 2008, 64:613-620. 10.1016/j.jpsychores.2008.02.016, 18501262.
24. Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P, et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 2007, 56:1770-1798. 10.1136/gut.2007.119446, 17488783.
25. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006, 130:1480-1491. 10.1053/j.gastro.2005.11.061, 16678561.